Two initiatives from different ends of the drug development spectrum are shining a bright light on nagging weaknesses in translational medicine and the urgent need to improve speed and efficiency in moving early stage discoveries into therapeutic candidates. Read More
It has been 10 years since the international human genome project (HGP) was officially declared completed two years ahead of schedule. This monumental undertaking has helped fuel the biopharmaceutical sector to its current lofty heights and one of the reasons that bioscience discoveries in overdrive can be traced back to the completion of the sequencing of the human genome. Read More
Johnson & Johnson has jumped into the early stage development pool with both feet. With the opening of its California Innovation Center based in Menlo Park earlier this month, the New Brunswick, N.J.-based company has established regional innovation centers, incubators, and entrepreneurs in residence to get J&J closer to early stage products that might be licensed or acquired by the health-care giant. Read More